Press monitoring
USDA set to approve second genetically-modified fruit
8.8.2006 | Press monitoring
The U.S. Department of Agriculture (USDA), Institute National de la Recherche Agronomique of France and Cornell University are planning to introduce genetically-modified plums for commercial use, RAW STORY has learned.
New NIAID Program Aims to Model Immune Responses and Key Infectious Diseases
8.8.2006 | Press monitoring
A new program at the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), aims to better understand the complex biochemical networks that regulate the interactions between infectious organisms and the human or animal cells they infect. The Program in Systems Immunology and Infectious...
'Lab-made sperm' fertility hope
8.8.2006 | Press monitoring
Scientists have proved for the first time that sperm grown from embryonic stem cells can be used to produce offspring.
Science group says biotech feed is safe
7.8.2006 | Press monitoring
DES MOINES, Iowa - A nonprofit consortium of scientists says in a new report that food products from livestock that eat biotech crops do not present a risk to consumers.
Much Needed New Antibiotic in Fight Against 'Superbugs'
7.8.2006 | Press monitoring
Tygacil (tigecycline), a new, expanded broad-spectrum IV antibiotic for the treatment of a wide range of infections including those caused by antibiotic resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), 1 will be available in the UK from today.
GM potato crops to produce vaccines
7.8.2006 | Press monitoring
German researchers obtained this year permission to plant genetically-modified potatoes that produce vaccines and proteins on an outdoor plantation
German biotech companies report new results on cultivated liver cells
6.8.2006 | Press monitoring
Prediction of toxicity and compound responses in hepatocytes continues to be a major concern for the pharmaceutical industry. Non-immortalised primary cells may best represent normal physiology. The German biotech company Bionas GmbH, Rostock, has made a first study investigating primary human hepatocytes with in vitro test in the Bionas 2500...
Study expands knowledge about autism
6.8.2006 | Press monitoring
U.S. researchers say they believe they've identified why people suffering from autism think in pictures.
Biotech Boom
5.8.2006 | Press monitoring
U.S. Bay Area is the Epicenter of this Leading-Edge Technology
China preferred over India in drug making
4.8.2006 | Press monitoring
NEW DELHI: Giving thumbs down to India's much touted cost-effective and high skill advantage in the pharmaceutical sector, a study by global consulting firm Bain & Co has said multinational executives consider China a better choice for low-cost drug manufacturing.
